Vanderbilt Health-One Hundred Oaks

Nashville, Tennessee 372212

2 studies enrolling now · 8 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Diabetes Mellitus, Type 2, Endometrial Cancer, Metastatic Breast Cancer, Obesity, Obstructive Sleep Apnea, Osteoarthritis, Knee, Overweight, SARS-CoV-2 Infection

Studies at this site

• A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities — Recruiting now
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) — Recruiting now
• A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes — Starting soon
• A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities — Running, not enrolling
• A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer — Running, not enrolling
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight — Completed
• A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 — Completed
• A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program — Completed